Zeng W, Liu M, Peng S, Yu G, Zhai X, Chen X, Lu F. Is the life-long entecavir treatment really inevitable in chronic hepatitis B patients? J Viral Hepat 2020;27:1509-10. [PMID: 32741086 DOI: 10.1111/jvh.13369][Reference Citation Analysis]
2
Lee H, Jang S, Ahn SH, Kim BK. Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level < 2000 IU/mL. Hepatol Int 2022. [PMID: 35322374 DOI: 10.1007/s12072-022-10310-1][Reference Citation Analysis]